FDA authorizes updated COVID-19 boosters for children as young as 5 years old
The U.S. Food and Drug Administration (FDA) has amended the emergency use authorizations of the Moderna and Pfizer-BioNTech vaccine bivalents to authorize their use as a single booster dose in younger age groups. Moderna’s vaccine bivalent is permitted for administration … Continued